Krina Tynke Zondervan is a Dutch biomedical scientist who is a Professor of Genomic Epidemiology at the University of Oxford. She serves on the board of the World Endometriosis Society.
Zondervan was made a Wellcome Trust Research Development Fellow in 2007. She was made Director of the Endometriosis CaRe centre in Oxford in 2012. She was promoted to Professor of Genomic Epidemiology and Fellow of St Edmund Hall in 2015.[1]
Zondervan's research considers the pathogenesis of women's health conditions through the use of genomic and environmental epidemiological research. She is particularly focussed on endometriosis, a chronic inflammatory condition that involves endometrial-like cells in the uterus. The condition impacts up to 10% of reproductive-age women and has very few effective treatments.[2][4] She has studied the genetic factors that underpin risk to endometriosis, and uses this work to design new therapeutic treatments.[5][6][7]
Zondervan founded the International Endometriosis Genome Consortium who oversee genome-wide association studies of endometriosis. The consortium, which research centres around the world who collect data on tens of thousands of women suffering from endometriosis.[8] Together with Stacey Missmer at Michigan State University Zondervan led the development of phenotypic tools (the World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Projec, WERF EPHect), which looks to standardise the reporting and processing of endometriosis patient information.[2][9]
